AI in drug discovery adoption barriers in developed countries worldwide 2023

According to a survey from 2023, the availability of sufficient/high quality data was the most often stated barrier to the adoption of artificial intelligence (AI) in drug discovery in high-income countries. Other frequently named barriers included the availability of suitable staff and the lack of understanding of AI. This statistic shows the leading barriers for AI adoption in drug discovery in developed countries.

根据2023年的一项调查，在高收入国家，药物发现领域人工智能（AI）应用的主要障碍是充足/高质量数据的可获得性，这一观点被频繁提及。其他常见障碍包括合适人员的可用性和对AI理解不足。这一统计数据揭示了发达国家在药物发现领域应用AI的主要障碍。